iBio, Inc. Common Stock (IBIO) is a publicly traded Healthcare sector company. As of July 28, 2026, IBIO trades at $1.39 with a market cap of $72.03M and a P/E ratio of -2.43. IBIO moved -3.45% today. Year to date, IBIO is -27.98%; over the trailing twelve months it is +95.77%. Its 52-week range spans $0.56 to $6.89. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces IBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IBIO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IBIO recently traded at $1.39. Market cap is $72.03M. P/E ratio is -2.43. Revenue is $300.00K.
| Metric | Value |
|---|---|
| Price | $1.39 |
| Market Cap | $72.03M |
| P/E Ratio | -2.43 |
| EPS | $-0.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.89 |
| 52-Week Low | $0.56 |
| Volume | 962.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $300.00K |
| Net Income | $-27.61M |
| Gross Margin | 0.00% |
6 analysts cover IBIO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.